Torrent Pharma buys out Unichem, while Divis gets USFDA clearance
Pharmaceutical stocks, which were lying low bounced back this past week with second quarter results largely in line with analyst expectations on recovery of domestic formulation business after disruption caused due to GST transition in the first q